Recently Added |View More
Roswell Park Offering CAR T Trial for Autoimmune Conditions
While most CAR T-cell therapies and clinical trials are directed at cancers, a new phase 1 trial at Roswell Park Comprehensive Cancer Center is open and recruiting patients with a variety of autoimmune conditions.
A new, first-in-humans clinical trial for hepatocellular carcinoma uses an “armored” CAR T-cell therapy designed to resist the hostile tumor microenvironment found in 77% of patients with this disease.
Roswell Park’s Stem Cell Transplant Program Recognized by Optum as Center of Excellence
Health services leader Optum has recognized Roswell Park Comprehensive Cancer Center as a Center of Excellence (COE) for the stem cell transplant program provided through its Transplant & Cellular Therapy Center.
A meta-analysis led by a researcher at Roswell Park Comprehensive Cancer Center has identified key factors that could improve outcomes for cancer patients treated with immune checkpoint inhibitors (ICIs) before or after a solid-organ transplant.
Experts from Roswell Park Comprehensive Cancer Center will give remarks on racial and ethnic disparities in outcomes among people with metastatic breast cancer; risk patterns for second cancers associated with human papillomavirus (HPV); ...
Roswell Park presentations include findings from KOMET-001 in AML, new insights on risk of organ rejection after ICI.
This site is intended for healthcare professionals
Click your preferred app store below to download our free mobile app — exclusively for physicians and physician offices — for direct access to a complete, up-to-date directory of Roswell Park physicians wherever you go. Email or call to refer a patient or ask a question with a click of a button.